ARTICANZ - Beta (ver 0.9)
Annotated Registry of Trials in Cancer, Australia and New Zealand Ed.
- Results - catype/medical-oncology/anal/metastatic
Home
By cancer type
By drug class
By site
Data
FAQ
About
⚠
ARTICANZ provides informational content about cancer drug trials in Australia/NZ that is updated weekly but may not be completely accurate, and should not replace medical advice from qualified healthcare professionals. The platform is intended to be useful, providing information "as is" without warranties. Non-medical users must always consult healthcare providers for all clinical decisions.
Search results
Gastrointestinal (Lower) / Anal - Metastatic
4
trial(s) found.
NCT04429542
Advanced
Phase 1
Recruiting
First-in-Human, Phase 1/1b, Open-label, Multicenter Study of Bifunctional EGFR/TGFβ Fusion Protein BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-Driven Advanced Solid Tumors (
BCA101X1101
)
bifunctional EGFR/TGF-beta fusion protein
Anal squamous cell carcinoma
Carcinoma
Colorectal cancer
Cutaneous squamous cell carcinoma
Epithelial Ovarian Cancer
Head and neck cancer
Head and neck squamous cell carcinoma
Pancreatic cancer
Squamous cell carcinoma
NSW
2298 - Waratah - Calvary Mater Newcastle Medical Oncology
VIC
3000 - Melbourne - Peter MacCallum Cancer Centre
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
NCT02628067
Advanced
Phase 2
Recruiting
A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158) (
KEYNOTE-158
)
anti-PD-1 monoclonal antibody
Anal cancer
Biliary tract cancer
Cancer
Cervical cancer
Cholangiocarcinoma
Colorectal cancer
Endometrial cancer
Endometrial carcinoma
Lung carcinoid tumour
Mesothelioma
Neuroendocrine tumour
Pancreatic neuroendocrine tumour
Salivary gland cancer
Salivary gland carcinoma
Small-cell lung cancer
Solid tumour
Thyroid cancer
Vulval cancer
NCT05858736
Advanced
Phase 1
Active not recruiting
Safety, Pharmacokinetics (PK) and Efficacy of AI-061, A 1:1 Co-formulation of AI-025 (Anti-PD-1) and ONC-392 (Anti-CTLA-4) Antibodies in Advanced Solid Tumors: An Open-Label Phase 1 Study (
PRESERVE-009
)
anti-CTLA-4 monoclonal antibody
anti-PD-1 monoclonal antibody
Adenocarcinoma
Anal cancer
Biliary tract cancer
Bladder cancer
Cancer
Cervical cancer
Clear cell renal cell carcinoma
Colorectal cancer
Endometrial cancer
Fallopian tube cancer
Gastric cancer
Head and neck squamous cell carcinoma
Hepatocellular carcinoma
Melanoma
Non-small cell lung cancer
Oesophageal cancer
Primary peritoneal serous carcinoma
NSW
2010 - Darlinghurst - St Vincent's Hospital Sydney - The Kinghorn Cancer Centre
QLD
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre
4215 - Southport - Tasman Oncology
SA
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre
5042 - Bedford Park - Southern Oncology Clinical Research Unit
NCT05551117
Advanced
Phase 2
Completed
A Phase 2, Open-label, Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors (
Tamarack
)
anti-B7H3 antibody-drug conjugate
Anal cancer
Carcinoma
Castrate-resistant prostate cancer
Head and neck squamous cell carcinoma
Laryngeal squamous cell carcinoma
Melanoma
Non-small cell lung cancer
Prostate cancer
Small-cell lung cancer
Small-cell neuroendocrine carcinoma
Squamous cell carcinoma
NSW
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital
VIC
3000 - Melbourne - Peter MacCallum Cancer Centre
3144 - Malvern - Cabrini Health, Cabrini Cancer Care Centre
QLD
4102 - Woolloongabba - Princess Alexandra Hospital
Additional search terms:
API and Webpage URLs:
Copy /Bookmark
Filters
Recruitment Status
Recruiting (2)
Active not recruiting (1)
Completed (1)
Recruitment Country and State
NSW (3)
VIC (2)
QLD (2)
SA (1)
Phase
Phase 1 (2)
Phase 2 (2)
Trial Type
Advanced (4)
Cancer Therapy Class
PD-1
75%
PD-1/PD-L1
75%
CTLA4
25%
AR
25%
B7H3
25%
CYP17A1
25%
androgen axis
25%
Facility
3000 - Melbourne - Peter MacCallum Cancer Centre (2)
2298 - Waratah - Calvary Mater Newcastle Medical Oncology (1)
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre (1)
2010 - Darlinghurst - St Vincent's Hospital Sydney - The Kinghorn Cancer Centre (1)
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre (1)
4215 - Southport - Tasman Oncology (1)
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre (1)
5042 - Bedford Park - Southern Oncology Clinical Research Unit (1)
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital (1)
3144 - Malvern - Cabrini Health, Cabrini Cancer Care Centre (1)
4102 - Woolloongabba - Princess Alexandra Hospital (1)
Cancer Type
Anal cancer
Cancer
Carcinoma
Gastrointestinal cancer
Head and neck cancer
Lower gastrointestinal cancer
Solid tumour
Colorectal cancer
Gynaecological cancer
HPV-related cancer
HPV16-positive cancer
Head and neck squamous cell carcinoma
Pancreatobiliary cancer
Upper gastrointestinal cancer
Viral-related cancer
Lung cancer
Respiratory tract cancer
Thoracic cancer
Pancreatic cancer
Squamous cell carcinoma
Biliary tract cancer
Cervical cancer
Endometrial cancer
Hepatobiliary cancer
Neuroendocrine carcinoma
Small-cell lung cancer
Small-cell neuroendocrine carcinoma
Melanoma
Non-small cell lung cancer
Urogenital cancer
Anal squamous cell carcinoma
Cutaneous squamous cell carcinoma
Epithelial Ovarian Cancer
Non-melanoma skin cancer
Ovarian cancer
Skin cancer
Cholangiocarcinoma
Endocrine gland cancer
Endometrial carcinoma
Gastro-entero-pancreatic neuroendocrine tumour
Lung carcinoid tumour
Mesothelioma
Neuroendocrine tumour
Pancreatic neuroendocrine tumour
Salivary gland cancer
Salivary gland carcinoma
Thyroid cancer
Vaginal and vulvar cancer
Vulval cancer
Adenocarcinoma
Bladder cancer
Clear cell renal cell carcinoma
Fallopian tube cancer
Gastric cancer
Gastroesophageal cancer
Hepatocellular carcinoma
High-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
Kidney cancer
Oesophageal cancer
Peritoneal cancer
Primary peritoneal serous carcinoma
Castrate-resistant prostate cancer
Laryngeal squamous cell carcinoma
Male genital cancers
Prostate adenocarcinoma
Prostate cancer
URLs for this search
API URL:
Copy
Bookmarkable URL:
Copy